Contact your healthcare provider immediately if you experience signs of a serious interaction, such as severe stomach pain, unusual bleeding or bruising, rash, difficulty breathing, or persistent dizziness
Patients experiencing nausea, vomiting, or diarrheacommon side effects, especially during dose initiation or escalationmay inadvertently decrease their consumption of both food and beverages while experiencing increased fluid losses, resulting in dehydration that manifests as oral dryness
However, specificity is not the same as proven safety, and for both BPC-157 and TB-500 the human safety database is essentially empty of controlled trial data
Anecdotal reports note altered food preferences in mixed-sex obesity trials like in a STEP clinical program, but these focus on energy intake, not sensitivity metrics